Skip to main content
. 2022 Dec 15;2(4):190–198. doi: 10.1093/psyrad/kkac023

Table 2:

Differences: in the intrinsic hippocampusamygdala global network between patients with MDD and healthy controls.

Measures Patients with MDD HCs Differences CI lower CI upper P value
Small-worldness index 0.924 0.747 −0.177 −0.066 0.054 <0.001***
Measures of segregation
 Average strength 16.964 13.997 −2.967 −3.727 3.865 0.244
 Local efficiency 1.262 1.043 −0.218 −0.365 0.441 0.405
 Mean clustering coefficient 0.394 0.304 −0.090 −0.100 0.097 0.143
 Transitivity 0.601 0.465 −0.137 −0.140 0.152 0.136
 Modularity 0.046 0.136 0.090 −0.047 0.052 0.004**
Measures of integration
 Characteristic path length 2.721 3.490 0.768 −0.691 0.600 0.029*
 Global efficiency 0.436 0.384 −0.052 −0.071 0.090 0.308
Measures of centrality
 Average degree 39.762 38.143 −1.619 −1.713 0.955 0.097
 Average eccentricity 5.746 6.443 0.698 −1.115 1.017 0.274
Measures of resilience
 Assortativity coefficient −0.074 −0.070 0.004 −0.034 0.028 0.739

Notes: Data are presented as the means. CI, 95% confidence interval of the difference between the groups. *P < 0.05; **P < 0.01; ***P < 0.001.